Zobrazeno 1 - 10
of 86
pro vyhledávání: '"aso pcr"'
Autor:
Mohammad Reza Mirinezhad, Maliheh Aghsizadeh, Hamideh Ghazizadeh, Sahar Ghoflchi, Mohammad Zamiri Bidary, Alireza Naghipour, Gordon A. Ferns, Tayebeh Hamzehloei, Alireza Pasdar, Majid Ghayour-Mobarhan
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background and aim premature ovarian insufficiency (POI) is defined as the menopause before 40 years of age, and its prevalence is reported to be two-fold higher in Iranian women than the average for woman globally. POI is associated with se
Externí odkaz:
https://doaj.org/article/b21b66d8fd694a58b9785684314e4265
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giulia Benintende, Federico Pozzo, Idanna Innocenti, Francesco Autore, Alberto Fresa, Giovanni D’Arena, Valter Gattei, Luca Laurenti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Measurable residual disease (MRD) is defined as the presence of residual cancer cells after treatment in patients with clinically undetectable disease, who would otherwise be considered in complete remission. It is a highly sensitive parameter which
Externí odkaz:
https://doaj.org/article/61a7f41b782c4e0aab90ebe52950a00f
Autor:
Mohammad Reza Mirinezhad, Hamideh Ghazizadeh, Maliheh Aghsizadeh, Mohammad Zamiri Bidary, Alireza Naghipour, Elahe Hasanzadeh, Mahdiyeh Yaghooti-Khorasani, Ali Ebrahimi Dabagh, Mohammad Reza Shadmand Foumani Moghadam, Nazanin Sheikh Andalibi, Zeynab Naseri Far, Habibollah Esmaily, Gordon A. Ferns, Tayebeh Hamzehloei, Alireza Pasdar, Majid Ghayour-Mobarhan
Publikováno v:
BMC Women's Health, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background and aim Primary Ovarian Insufficiency (POI) is defined by the occurrence of menopause before the age of 40 years. It is often associated with cardiovascular disease (CVD). The purpose of this study was to explore the relationship
Externí odkaz:
https://doaj.org/article/d6e7b2b57c56494a93d145376f59cb1f
Autor:
Lenka Sedlarikova, Lena Kubiczkova, Fedor Kryukov, Jana Pelcova, Zdenek Adam, Ludek Pour, Roman Hajek, Sabina Sevcikova
Publikováno v:
Biomedical Papers, Vol 159, Iss 4, Pp 554-561 (2015)
Aims: Multiple myeloma (MM), the second most common hematological cancer, is a lymphoproliferative disease of terminally differentiated B lymphocytes characterized by expansion of monoclonal plasma cells. With the introduction of new drugs, MM has be
Externí odkaz:
https://doaj.org/article/979666c699f247469def1d8d33f8a5fc
Publikováno v:
پیاورد سلامت, Vol 2, Iss 4, Pp 64-71 (2009)
Background and Aim: Thalassemia is a genetic disease whit relative or complete lack of alpha or beta globin chain. Patients with moderate and severe form need to have multitransfusion in early life. Occurrence of all immunization against blood group
Externí odkaz:
https://doaj.org/article/8b0676648f5745b090d72a5fbfce4a65
Publikováno v:
پیاورد سلامت, Vol 2, Iss 4, Pp 64-71 (2009)
Background and Aim: Thalassemia is a genetic disease whit relative or complete lack of alpha or beta globin chain. Patients with moderate and severe form need to have multitransfusion in early life. Occurrence of all immunization against blood group
Externí odkaz:
https://doaj.org/article/719d546645274199b6ce5db29c9111bd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Rambam Maimonides Medical Journal, Vol 5, Iss 4, p e0027 (2014)
Achievement of complete response (CR) to therapy in chronic lymphocytic leukemia (CLL) has become a feasible goal, directly correlating with prolonged survival. It has been established that the classic definition of CR actually encompasses a variety
Externí odkaz:
https://doaj.org/article/98e150baa142450ab0938b5fd6f2e1b4
Autor:
Fatemeh Nadali, Sh Ferdowsi, P Karimzadeh, Bahram Chahardouli, N Einollahi, SA Mousavi, Babak Bahar, H Dargahi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, SH Ghaffari
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 3, Iss 4, Pp 43-45 (2009)
"nJAK2 is a tyrosine kinase that plays an important role in the signaling pathways of many hematopoietic growth factor receptors. A single acquired point mutation – V617F – in JAK2 occurs in the great majority of patients with polycythemia vera (
Externí odkaz:
https://doaj.org/article/1385c902ca1240e792c3efd0e5890970